A study to assess the utility of treatment with atezolizumab plus carboplatin and etoposide in SCLC patients previously treated with platinum-based chemotherapy
Latest Information Update: 21 Aug 2020
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 21 Aug 2020 New trial record
- 11 Aug 2020 Results published in the Investigational New Drugs